I dobbeltblindede kliniske forsøg hvor Enbrel sammenlignes med placebo, var reaktioner på injektionsstedet den mest almindelige bivirkning blandt patienter behandlet med Enbrel.
In double-blind clinical trials comparing Enbrel to placebo, injection site reactions were the most frequent adverse events among Enbrel-treated patients.